Speech Disorders in Parkinson’s Disease: Pathophysiology, Medical Management and Surgical Approaches
Khashayar Dashtipour, Ali Tafreshi, Jessica K. Lee et al. · Neurodegenerative Disease Management · 2018
The prevalence of speech disorders among individuals with Parkinson's disease (PD) has been reported to be as high as 89%. Speech impairment in PD results from a combination of motor and nonmotor deficits. The production of speech depends upon the coordination of various motor activities: respiration, phonation, articulation, resonance and prosody. A speech disorder is defined as impairment in any of its inter-related components. Despite the high prevalence of speech disorders in PD, only 3-4% receive speech treatment. Treatment modalities include pharmacological intervention, speech therapy, surgery, deep brain stimulation and vocal fold augmentation. Although management of Parkinsonian dysarthria is clinically challenging, speech treatment in PD should be part of a multidisciplinary approach to patient care in this disease.
Cited by 149 works. doi:10.2217/nmt-2018-0021
Authors
References
- Differential Diagnostic Patterns of Dysarthria
- The mysterious motor function of the basal ganglia
- Parkinson disease
- The prevalence of Parkinson's disease: A systematic review and meta‐analysis
- EPIDEMIOLOGY OF PARKINSON'S DISEASE
- Clusters of Deviant Speech Dimensions in the Dysarthrias
- Frequency and Cooccurrence of Vocal Tract Dysfunctions in the Speech of a Large Sample of Parkinson Patients
- The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
- Swallowing and speech production in Parkinson's disease
- High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases